Wearable Medication Adherence Tracker Market Size Worth US$ 6,404.8 Million at a CAGR of 10.3% by 2034 | Fact.MR Report

Rising healthcare costs and need for efficient management is driving the wearable medication adherence tracker market

/EIN News/ -- Rockville, MD, Dec. 16, 2024 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global wearable medication adherence tracker market is estimated to reach a valuation of US$ 2,403.0 million in 2024 and is expected to grow at a CAGR of 10.3% during the forecast period of (2024 to 2034).

The healthcare providers and patients are suffering from high cost for the management of chronic disease conditions such as diabetes (DM), hypertension (HTN) related problems. Management of these conditions require long term adherence. Both patients and healthcare providers suffer significant costs in managing these chronic illnesses. Ignorance of this could lead to more severe conditions. The conventional approach to drug management, which involves manual tracking, frequent doctor visits, and hospital stays, tends to be more expensive. This is accomplished by wearables, which lower the number of hospital visits and overall cost of care by remotely monitoring the patient's health and prescription compliance in real time.

Patients avoid issues that could result in costly emergency treatments or readmissions because the wearables make sure they take their prescriptions as directed. They also give patients the ability to actively manage their existing diseases, which improves health outcomes and reduces the need for regular monitoring by medical personnel. Because of the increasing need for affordable solutions, wearable technology has become a crucial component of contemporary healthcare administration.

For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=10509

Key Takeaways from Market Study

• The global wearable medication adherence tracker market is projected to grow at 3% CAGR and reach US$ 6,404.8 million by 2034
• The market created an absolute $ opportunity of US$ 4,001.8 million growing at a CAGR of 3% between 2024 to 2034
• North America is a prominent region that is estimated to hold a market share of 9% in 2024
• Predominating market players include Philips Healthcare, Proteus Digital Health, iRhythm Technologies, E-pill Medication Reminders, Omron Healthcare, EtectRx, Tenovi, Dassault Systèmes, and Medtronic among others.
• Smartwatches with medication features is holding highest share of 7% in wearable medication adherence tracker market in 2024, with an absolute dollar opportunity of US$ 1,167.7 million.
• North America and Western Europe are expected to create an absolute $ opportunity of US$ 2,221.0 million

“High prevalence of diabetes and cardiovascular diseases making surge in the demand for wearable medication adherence trackers in the management of chronic diseases” says a Fact.MR analyst.

Leading Players Driving Innovation in the Wearable Medication Adherence Tracker Market:

Key competitors in the wearable medication adherence tracker market are Philips Healthcare, Proteus Digital Health, iRhythm Technologies, E-pill Medication Reminders, Omron Healthcare, EtectRx, Tenovi, Dassault Systèmes, and Medtronic among others.

Most of the chronic disease conditions such as DM, HTN, and heart diseases involve complex medication management that makes consistent adherence quite difficult for patients. These wearable trackers make things quite simple by allowing real-time reminders, monitoring, and ensuring that patients are on course with their treatment. This allows the tracking of medication adherence, preventing complications and hospitalizations that improve patient outcomes. As these chronic disease conditions are continuously on surge, patients along with healthcare providers are taking initiatives in the adoption of wearable medication adherence trackers to improve adherence and quality of life of affected individuals.

Wearable Medication Adherence Tracker Industry News:

• In order to streamline and automate ongoing patient monitoring both within and outside of hospitals, Royal Philips and smartQare formed a strategic cooperation in April 2024. Through this project, wearable biosensors are used to lessen the clinical workload.
• In January 2023, Masimo's recently released W1 wearable watch was included to Philips and Medtech's patient monitoring collaboration.
  

Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=S&rep_id=10509

More Valuable Insights on Offer

Fact.MR, in its new offering, presents an unbiased analysis of the global Wearable medication adherence tracker market, presenting historical data for 2019 to 2023 and forecast statistics for 2024 to 2034.

The study reveals essential insights on the basis of the product type (smartwatches with medication features; pill-tracking wearables; wearables with biometric monitoring and adherence tracking; patch-based wearables; multifunctional health devices; and medication adherence platforms with wearables), medication type (chronic disease medications – diabetes, cardiovascular diseases, respiratory diseases; mental health and neurology - depression or anxiety medications, alzheimer’s or dementia medications; oncology medications; lifestyle/general wellness) and end user (patients/individuals, healthcare providers, caregivers) across major regions of the world (North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia & Pacific, and Middle East & Africa).

Check out More Related Studies Published by Fact.MR:

Wearable Biometric Monitor Market: Size was valued at US$ 9,800.0 million in 2023 and has been forecasted to expand at a noteworthy CAGR of 8.9% to end up at US$ 25,034.1 million by 2034.

Cardiovascular Disease Monitoring and Diagnostic Devices Market: Size is projected to rise at a CAGR of 6% from 2022 to 2027. The market is expected to secure a market value of around US$ 4.2 billion by 2027, up from US$ 3.14 billion in 2022.

Diabetes Management Software Market: Size is anticipated to surge at a CAGR of 9.9% from 2022 to 2032. At present, the global diabetes management software market is valued at US$ 25.85 billion and is anticipated to reach a market valuation of US$ 66.26 billion by the end of 2032.

Wearable Adhesives Market: Size is anticipated to increase rapidly at a CAGR of 9.3% from 2023 to 2033. Currently, the global wearable adhesives market is valued at US$ 370 million and is thus expected to reach a market size of US$ 900 million by the end of 2033.

Patient Engagement Solutions Market: Size is expanding gradually, with a compound annual growth rate (CAGR) of 8.6% through 2032. By 2022, the market was valued at over US$29 billion. The market is anticipated to reach US$ 66.4 billion by the end of 2032.

About Us:

Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning.

With its unwavering dedication to providing reliable market intelligence, FACT.MR continues to assist companies in navigating dynamic market challenges with confidence and achieving long-term success. With a global presence and a team of experienced analysts, FACT.MR ensures its clients receive actionable insights to capitalize on emerging opportunities and stay competitive.

Contact:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Sales Team: sales@factmr.com
Follow Us: LinkedIn | Twitter | Blog